ULTRALIFE CORP - Common Stock (ULBI) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
ULBI on Nasdaq
Shares outstanding
16,574,821
Price per share
$5.72
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
5,711,133
Total reported value
$38,948,673
% of total 13F portfolios
0%
Share change
+103,085
Value change
-$191,018
Number of holders
62
Price from insider filings
$5.72
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ULTRALIFE CORP - Common Stock (ULBI) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Visionary Wealth Advisors 7.8% $6,955,458 1,292,836 Visionary Wealth Advisors 31 Dec 2024

As of 30 Sep 2025, 62 institutional investors reported holding 5,711,133 shares of ULTRALIFE CORP - Common Stock (ULBI). This represents 34% of the company’s total 16,574,821 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of ULTRALIFE CORP - Common Stock (ULBI) together control 32% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Visionary Wealth Advisors 6.6% 1,095,042 +0.19% 0.35% $7,468,187
DIMENSIONAL FUND ADVISORS LP 6.1% 1,010,587 -0.83% 0% $6,892,203
VANGUARD GROUP INC 3.1% 505,625 0% 0% $3,448,363
Janney Montgomery Scott LLC 2.9% 475,667 +6.6% 0.01% $3,244,000
Truffle Hound Capital, LLC 1.5% 250,000 0% 1.1% $1,705,000
RBF Capital, LLC 1.4% 225,000 0% 0.07% $1,534,500
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 1.3% 219,018 +211% 0% $1,493,703
RENAISSANCE TECHNOLOGIES LLC 1.3% 214,590 -9.1% 0% $1,463,504
Connor, Clark & Lunn Investment Management Ltd. 0.92% 151,954 +4.2% 0% $1,036,326
BlackRock, Inc. 0.88% 145,826 +0.33% 0% $994,533
GEODE CAPITAL MANAGEMENT, LLC 0.72% 118,834 +5.1% 0% $810,621
RAYMOND JAMES FINANCIAL INC 0.7% 115,985 -0.09% 0% $791,018
Teton Advisors, LLC 0.66% 110,200 0% 0.46% $751,564
Ancora Advisors LLC 0.64% 105,321 +24% 0.01% $718,289
ACADIAN ASSET MANAGEMENT LLC 0.52% 85,947 0% 0% $585,000
CITADEL ADVISORS LLC 0.49% 80,921 +79% 0% $551,881
Perritt Capital Management Inc 0.39% 65,000 +62% 0.21% $443,300
LSV ASSET MANAGEMENT 0.39% 64,500 +232% 0% $440,000
Walleye Capital LLC 0.38% 63,707 +105% 0% $434,482
BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.36% 59,579 +45% 0.01% $406,329
MILLENNIUM MANAGEMENT LLC 0.3% 50,174 -48% 0% $342,187
Russell Investments Group, Ltd. 0.3% 48,997 +4671% 0% $334,158
STATE STREET CORP 0.25% 40,720 +8.2% 0% $277,710
TWO SIGMA INVESTMENTS, LP 0.25% 40,645 +135% 0% $277,199
MARSHALL WACE, LLP 0.23% 38,082 0% $259,718

Institutional Holders of ULTRALIFE CORP - Common Stock (ULBI) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 958 $5,162 -$457 $5.72 3
2025 Q3 5,711,133 $38,948,673 -$191,018 $6.82 62
2025 Q2 5,608,393 $50,360,042 -$1,967,740 $8.98 61
2025 Q1 5,927,266 $31,887,382 -$1,903,351 $5.38 70
2024 Q4 6,273,891 $46,738,241 +$1,465,157 $7.45 66
2024 Q3 6,043,039 $54,690,997 -$941,698 $9.04 74
2024 Q2 6,048,765 $64,235,625 +$10,026,670 $10.62 70
2024 Q1 5,150,472 $45,375,589 +$1,506,401 $8.81 60
2023 Q4 0 $0 -$117,813 $5.72 0
2023 Q3 4,669,553 $45,574,879 +$5,100,330 $9.76 49
2023 Q2 4,172,822 $20,195,823 -$556,184 $4.84 31
2023 Q1 4,274,553 $17,182,141 +$80,312 $4.02 27
2022 Q4 4,237,358 $16,355,291 +$422,173 $3.86 29
2022 Q3 4,140,684 $19,915,939 -$1,043,965 $4.81 24
2022 Q2 4,369,230 $20,015,834 -$529,138 $4.55 24
2022 Q1 4,495,780 $24,139,616 -$1,058,801 $5.37 25
2021 Q4 4,689,456 $28,326,877 -$1,956,324 $6.04 28
2021 Q3 4,936,100 $35,103,639 -$880,622 $7.09 38
2021 Q2 5,036,358 $42,364,665 -$4,365,648 $8.38 47
2021 Q1 5,559,092 $46,036,445 +$4,680,732 $8.28 54
2020 Q4 5,363,782 $34,704,477 -$1,509,173 $6.47 47
2020 Q3 5,572,496 $32,885,003 -$1,117,392 $5.90 43
2020 Q2 5,748,504 $40,229,143 +$1,780,456 $7.01 45
2020 Q1 5,574,996 $28,990,300 -$2,309,488 $5.20 35
2019 Q4 6,009,484 $44,408,848 -$332,729 $7.39 31
2019 Q3 5,228,967 $45,279,165 -$143,403 $8.66 32
2019 Q2 5,257,125 $41,793,988 -$42,008 $7.95 35
2019 Q1 5,169,343 $53,084,568 +$3,421,696 $10.27 41
2018 Q4 5,024,594 $33,914,688 -$824,932 $6.75 32
2018 Q3 5,314,007 $41,271,038 +$1,685,512 $8.15 34
2018 Q2 5,241,973 $50,322,000 +$3,862,544 $9.60 35
2018 Q1 4,808,758 $48,087,000 +$6,330,425 $10.00 36
2017 Q4 4,281,775 $28,040,000 +$1,326,494 $6.55 33
2017 Q3 4,064,530 $27,437,000 +$2,069,732 $6.75 35
2017 Q2 3,813,053 $27,448,000 +$4,378,469 $7.20 40
2017 Q1 3,220,454 $17,417,000 +$962,230 $5.44 32
2016 Q4 3,156,610 $15,623,850 -$473,771 $4.95 36
2016 Q3 3,243,982 $13,303,864 -$361,041 $4.11 38
2016 Q2 3,339,016 $16,727,024 -$208,606 $5.01 39
2016 Q1 3,375,920 $17,284,000 -$185,744 $5.12 43
2015 Q4 3,395,286 $21,931,000 +$1,983,244 $6.46 44
2015 Q3 3,090,818 $18,203,000 -$3,298,227 $5.89 33
2015 Q2 3,631,576 $15,215,000 -$4,791,453 $4.19 32
2015 Q1 4,850,992 $19,217,000 -$260,079 $3.94 30
2014 Q4 4,953,259 $15,502,000 -$462,543 $3.13 29
2014 Q3 5,096,103 $16,509,000 -$396,281 $3.24 34
2014 Q2 5,217,151 $20,034,000 -$206,789 $3.84 30
2014 Q1 5,269,934 $22,379,000 +$772,359 $4.25 32